SCOPUS 정보 검색 플랫폼

Volumn 131, Issue 6, 2013, Pages 567-568

Relationship between Factor v Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen

(5) Onitilo, Adedayo A a Doi, Suhail A R b Engel, Jessica M a Glurich, Ingrid a Berg, Richard a

a MARSHFIELD CLINIC (United States)

b UNIVERSITY OF QUEENSLAND (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; TAMOXIFEN;

BLOOD CLOT; BODY MASS; BREAST CANCER; CANCER STAGING; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; GENE MUTATION; HUMAN; LETTER; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; TAMOXIFEN; VENOUS THROMBOSIS;

EID: 84878870852 PISSN: 00493848 EISSN: 18792472 Source Type: Journal
DOI: 10.1016/j.thromres.2013.01.035 Document Type: Letter

Times cited : (3)

References (6)

1
- 84861794862
- Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: A population-based experience
- A.A. Onitilo, S.A. Doi, J.M. Engle, I. Glurich, J. Johnson, and R. Berg Clustering of venous thrombosis events at the start of tamoxifen therapy in breast cancer: a population-based experience Thromb Res 130 2012 27 31
- (2012) Thromb Res , vol.130 , pp. 27-31
- Onitilo, A.A.¹ Doi, S.A.² Engle, J.M.³ Glurich, I.⁴ Johnson, J.⁵ Berg, R.⁶

2
- 84878886748
- Tamoxifen-associated thromboembolism in breast cancer
- A. Eroglu Tamoxifen-associated thromboembolism in breast cancer Thromb Res 131 6 2013 566
- (2013) Thromb Res , vol.131 , Issue.6 , pp. 566
- Eroglu, A.¹

3
- 84874181053
- Tamoxifen-induced venothromboembolic events: Exploring validation of putative genetic association
- I. Glurich, P.H. Chyou, J.M. Engel, D.S. Cross, and A.A. Onitilo Tamoxifen-induced venothromboembolic events: Exploring validation of putative genetic association Clin Med Res 11 2013 16 25
- (2013) Clin Med Res , vol.11 , pp. 16-25
- Glurich, I.¹ Chyou, P.H.² Engel, J.M.³ Cross, D.S.⁴ Onitilo, A.A.⁵

4
- 77954730914
- Factor v Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer
- J.E. Garber, S. Halabi, S.M. Tolaney, E. Kaplan, L. Archer, and J.N. Atkins Factor V Leiden mutation and thromboembolism risk in women receiving adjuvant tamoxifen for breast cancer J Natl Cancer Inst 102 2010 942 949
- (2010) J Natl Cancer Inst , vol.102 , pp. 942-949
- Garber, J.E.¹ Halabi, S.² Tolaney, S.M.³ Kaplan, E.⁴ Archer, L.⁵ Atkins, J.N.⁶

5
- 70349564128
- Factor v Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer
- A. Eroglu, R. Cam, Y. Egin, and N. Akar Factor V Leiden and prothrombin G20210A polymorphisms are not associated with disease-free survival in breast cancer Breast Cancer Res Treat 116 2009 619 620
- (2009) Breast Cancer Res Treat , vol.116 , pp. 619-620
- Eroglu, A.¹ Cam, R.² Egin, Y.³ Akar, N.⁴

6
- 67349108801
- Dihydrofolate reductase (DHFR) 19-bp intron-1deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer
- R. Cam, A. Eroglu, Y. Egin, and N. Akar Dihydrofolate reductase (DHFR) 19-bp intron-1deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer Breast Cancer Res Treat 115 2009 431 432
- (2009) Breast Cancer Res Treat , vol.115 , pp. 431-432
- Cam, R.¹ Eroglu, A.² Egin, Y.³ Akar, N.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.